Syncona (LON:SYNC) Trading 1.2% Higher - Still a Buy?

Key Points

• Shares rose 1.2% intraday to GBX 90.20 (high GBX 91.50) on volume of 356,971 shares, about 20% below the average session volume.
• Fundamentals and technicals point to caution: Syncona trades below its 50‑day (GBX 95.34) and 200‑day (GBX 96.99) moving averages, has a market cap of £548.6m and a negative P/E of -5.99.

Syncona (LON:SYNC - ) shares traded up 1.2% during mid-day trading on Wednesday . The stock traded as high as GBX 91.50 and last traded at GBX 90.20. 356,971 shares traded hands during mid-day trading, a decline of 20% from the average session volume of 444,246 shares. The stock had previously closed at GBX 89.10.

Syncona Stock Performance

The company has a 50-day moving average of GBX 95.34 and a 200-day moving average of GBX 96.99. The firm has a market capitalization of £548.59 million, a price-to-earnings ratio of -5.99 and a beta of 0.42.

Syncona Company Profile

Syncona's purpose is to invest to extend and enhance human life. We do this by creating, building and scaling companies to deliver transformational treatments to patients in areas of high unmet need. We aim to build and maintain a diversified portfolio of 20-25 globally leading life science businesses, across development stage, modality and therapeutic area, for the benefit of all our stakeholders. We focus on developing treatments that deliver patient impact by working in close partnership with world-class academic founders and experienced management teams.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.